Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.11.008Source: DataRank Database

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer is a research paper published in Annals of Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 22 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access22 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (17)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Aris Spathis ORCID,Alejandro A. Schäffer ORCID,N. Gavrielatou,Fengshen Kuo ORCID,Dongya Jia ORCID

Live enrichment

PubMed:39551185 PMC:PMC11845298

National Cancer Institute

Grant: 1ZIABC011803-01

NCI NIH HHS

Grant: P30 CA008748

Intramural NIH HHS

Grant: ZIA BC011803

National Institutes of Health

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11845298/

publisherhttps://api.elsevier.com/content/article/PII:S0923753424049147?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0923753424049147?httpAccept=text/plain

MeSH Terms

B-LymphocytesLymphocytes, Tumor-InfiltratingHumansHead and Neck NeoplasmsPrognosisFemaleMaleTumor MicroenvironmentBiomarkers, TumorSquamous Cell Carcinoma of Head and NeckImmune Checkpoint Inhibitors

Keywords

ImmunotherapyB cellsHead And Neck CancerTumor MicroenvironmentLiquid BiopsyTreatment Response Biomarker

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer

FAIR Checklist

Authors (24)

Funding (4 grants)

Open Access

Topics

Annotations (Europe PMC)